Shen S - Search Results

1

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

Yan N, Guo S, Zhang H, Zhang Z, Shen S, Li X. Yan N, et al. Among authors: shen s. Front Oncol. 2022 Mar 31;12:863043. doi: 10.3389/fonc.2022.863043. eCollection 2022. Front Oncol. 2022. PMID: 35433454 Free PMC article. Review.

2

[The distribution of donor hematopoietic stem cell and the ratio of lymphocytes from donor origin to recipient origin in recipient mice after allogeneic bone marrow transplantation].

Shen SJ, Li XY, Wang LP. Shen SJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Jul;26(7):393-6. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16251017 Chinese.

3

Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.

Huang SY, Shen SJ, Li XY. Huang SY, et al. World J Surg Oncol. 2013 Oct 2;11:252. doi: 10.1186/1477-7819-11-252. World J Surg Oncol. 2013. PMID: 24088577 Free PMC article.

4

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors.

Liu RQ, Shen SJ, Hu XF, Liu J, Chen LJ, Li XY. Liu RQ, et al. Cancer Cell Int. 2013 Oct 18;13(1):99. doi: 10.1186/1475-2867-13-99. Cancer Cell Int. 2013. PMID: 24139471 Free PMC article.

5

Askin's tumor: 11 cases and a review of the literature.

Zhang KE, Lu R, Zhang P, Shen S, Li X. Zhang KE, et al. Among authors: shen s. Oncol Lett. 2016 Jan;11(1):253-256. doi: 10.3892/ol.2015.3902. Epub 2015 Nov 10. Oncol Lett. 2016. PMID: 26870198 Free PMC article.

6

[Association between the ALK Gene Status and the Efficacy of First-line  Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma].

Chen M, Cao H, Ji Y, Mao Y, Shen S, Li X. Chen M, et al. Among authors: shen s. Zhongguo Fei Ai Za Zhi. 2017 Nov 20;20(11):732-736. doi: 10.3779/j.issn.1009-3419.2017.11.02. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29167001 Free PMC article. Chinese.

7

[Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung  Adenocarcinoma].

Li P, Li B, Shi Y, Zhang F, Shen S, Li X. Li P, et al. Among authors: shen s. Zhongguo Fei Ai Za Zhi. 2019 Mar 20;22(3):137-142. doi: 10.3779/j.issn.1009-3419.2019.03.03. Zhongguo Fei Ai Za Zhi. 2019. PMID: 30909992 Free PMC article. Chinese.

8

[Characteristics of Epidermal Growth Factor Receptor with Rare Mutations in Non-small Cell Lung Cancer and the Effect of EGFR Tyrosine Kinase Inhibitors on Them].

Shi Y, Li P, Li B, Zhang F, Huang S, Shen S, Li X. Shi Y, et al. Among authors: shen s. Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):299-305. doi: 10.3779/j.issn.1009-3419.2019.05.06. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31109439 Free PMC article. Chinese.

9

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M.

Wang Y, Zheng R, Hu P, Zhang Z, Shen S, Li X. Wang Y, et al. Among authors: shen s. BMC Cancer. 2021 Nov 13;21(1):1215. doi: 10.1186/s12885-021-08942-x. BMC Cancer. 2021. PMID: 34774017 Free PMC article.

10

Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence.

Wang Y, Shen S, Hu P, Geng D, Zheng R, Li X. Wang Y, et al. Among authors: shen s. Cancer Med. 2022 Dec;11(23):4491-4500. doi: 10.1002/cam4.4834. Epub 2022 May 26. Cancer Med. 2022. PMID: 35616090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,742 results

Search Page

Filters